Testing effectiveness (Phase 2)Not Yet RecruitingNCT06299371
What this trial is testing
Adebrelimab Plus Chemotherapy as Neoadjuvant Therapy in Resectable NSCLC Harboring Driver Gene Mutations
Who this might be right for
Non Small Cell Lung Cancer
Liaoning Cancer Hospital & Institute 36